APO IRB 150 (Irbesartan 150 mg)

Pill imprint APO IRB 150 has been identified as Irbesartan 150 mg.

Irbesartan is used in the treatment of high blood pressure; diabetic kidney disease and belongs to the drug class angiotensin receptor blockers. There is positive evidence of human fetal risk during pregnancy. Irbesartan 150 mg is not a controlled substance under the Controlled Substance Act (CSA).

Consumer resources

Professional resources

Related treatment guides

Disclaimer:
Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.